Press Release

Hepatitis C Drug Market by Top International Players, Growth Factor, Share, Trends, Size Forecast till 2026

Hepatitis C Drug Market by top key Players are AbbVie Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp.,

Hepatitis C Drug Market The global Hepatitis C Drug market will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drug: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period.

Get PDF Brochure of this [email protected]

Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stages of hepatitis C can also lead to liver damage, thereby creating severe health risks. The severity of hepatitis C has created a huge emphasis on the research and development of drugs associated with the treatment of this disease. Several new drugs have been launched in recent times, due to the high prevalence of hepatitis C across the world. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage.

Top players in the global Type 1 Hepatitis C Drug Market include:

  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Janssen Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp.
  • Hoffmann-La Roche Ltd
  • Vertex Pharmaceuticals Incorporated

Browse Complete Report [email protected]

Huge Hepatitis C Patient Pool Will Offer Growth Opportunities for the Market in North America

The high prevalence of hepatitis C has created a need for efficient drugs at low cost. Fortune Business Insights has identified increasing hepatitis C incidence as a primary growth driver. The increased adoption of Hepatitis C Drug will favor the growth of the market in North America. Fortune Business Insights has predicted that the Hepatitis C Drug market in North America will witness considerable growth, driven by the high demand for Hepatitis C Drug.

Furthermore, recent drug advancements will fuel the demand for related drugs, subsequently aiding market growth. Fortune Business Insights states that the Hepatitis C Drug market in North America was valued at US$ 3,736.6 Mn in 2018.


By Product Type

  • NS5A Inhibitor (Protease Inhibitors)
  • Fixed-dose Combination

By Disease Type

  • Acute Hepatitis C
  • Chronic Hepatitis C

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Fortune Business Insights profiles a few of the prominent companies that are operating in the global market. Some of the leading companies that have established standout market positions are AbbVie Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company,  Janssen Pharmaceuticals, Inc.,  Merck Sharp & Dohme Corp.,  F. Hoffmann-La Roche Ltd,  and Vertex Pharmaceuticals Incorporated.

More Trending Topics From Fortune Business [email protected]

Surgical Stapling Devices Market 2019 Worldwide Share, Business Advancements, Industry Analysis, Trends, Forecast 2026

Orphan Drugs Market 2019: Industry Trends, Size, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Global Industry Forecast up to 2025

Transrectal Ultrasound Market 2019: Report Explored in Latest Research, Analysis Of Industry Forecast– 2026

Breast Cancer Therapeutics Market 2019 Global Size, Trends, Revenue, Share, Demands Research Report, Forecast till 2026


Jesus Rust

Jesus is leading the environment column. He is a very renowned environmentalist and has worked in many projects, some of which are based in faraway lands too. He always encourages environment conservation and sometimes keeps small group talks about the concerns. His writing and editing skills act the cheery on the top of the cake.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *